Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-020823

SVP, Chief Accounting Officer sold 7,711 shares at $9.12 ($70,324)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sabatini Brent SVP, Chief Accounting Officer 2026-03-23 Sale 10b5-1 −7,711 $9.12 $70,324 61,902 D: show line 1 in the form
Open-market sales · 7,711 sh · avg $9.12 · $70,324
Loading xslF345X06/wk-form4_1774384534.xml…